Screener
Aquestive Therapeutics, Inc. AQST Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $506.49M.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000030
FAQ
- What is Aquestive Therapeutics, Inc.'s market capitalization?
- Aquestive Therapeutics, Inc. (AQST) reported market capitalization of $506.49M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s market capitalization changed year-over-year?
- Aquestive Therapeutics, Inc.'s market capitalization increased by 76.6% year-over-year, from $286.73M to $506.49M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s market capitalization has grown at a 29.7% compound annual growth rate (CAGR), from $214.88M to $788.14M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Aquestive Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude